Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer | Zendy

Rashid Farah | Zendy; Omar Nabil E. | Zendy; Aaekl Hassan | Zendy; Al Homsi Ussama | Zendy; Shablak Alaaeldin | Zendy

Open Access

Successful rechallenge with cisplatin following cisplatin induced ischemic cerebrovascular accident in a patient with small cell lung cancer

Author(s) -

Rashid Farah,

Omar Nabil E.,

Aaekl Hassan,

Al Homsi Ussama,

Shablak Alaaeldin

Publication year - 2022

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.6469

Subject(s) - medicine , cisplatin , nephrotoxicity , lung cancer , chemotherapy , regimen , oncology , adverse effect , toxicity

Cisplatin is a widely used platinum‐based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have small‐cell lung cancer who developed ischemic cerebrovascular accident (CVA) after receiving chemotherapy regimen including cisplatin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research